Clinical Application of Continuous Monitoring Data for the Pulse Rate, Exercise, and Calorie Intake by Wearable Activity Trackers in the Patients With Thyrotoxicosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Thyrotoxicosis
- Sponsor
- Seoul National University Bundang Hospital
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The study is a single-center prospective cohort study of clinical application of continuously monitored data by wearable activity trackers in the patients with thyrotoxicosis. The purpose of the study is to evaluate the association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status along with the treatment.
Detailed Description
Activity trackers to be used: Fitbit Charge HR (TM) Data which ware provided by Fitbit app (TM) will be analyzed in this study.
Investigators
Jae Hoon Moon
Assistant professor
Seoul National University Bundang Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing newly developed or recurrent thyrotoxicosis who are treated and followed-up in Seoul National University Bundang Hospital
- •Patients who can use wearable activity trackers and smartphone applications
- •In case of Graves' disease, patients who will treated by anti-thyroid drugs
Exclusion Criteria
- •Patients who have thyrotoxic periodic paralysis
- •In case of Graves' disease, patients who will treated by radioactive iodine therapy or thyroidectomy
- •Patients who have thyrotoxicosis due to toxic nodular disease
Outcomes
Primary Outcomes
Association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status
Time Frame: continuous monitoring through the study period (average 3 months)
Secondary Outcomes
- Association between user-generated dietary parameters on mobile applications and the thyrotoxic status(continuous monitoring through the study period (average 3 months))